The prevalence of benign prostatic hyperplasia in patients with androgenetic alopecia is reported to be 2.7% to 10.7% in the general population in Asia, and the highest incidence in the Philippines and Malaysia is reported in the Andaman region.[] However, no studies have examined the association of finasteride with hair loss in Asian men and women. This study aimed to evaluate the associations of finasteride and prostate-specific antigen (PSA) and prostate-specific antigen (PSA) with prostate volume and the hair density in Asian men with benign prostate hyperplasia (BPH) and their associations with prostate volume and hair density in Filipino men. This was a case-control study. A total of 533 patients with prostate cancer were included in the study, with an average age of 50.9 ± 4.3 years. The prostate volume (mean ± SD) and hair density (mean ± SD) were significantly increased in both groups. The results were obtained using receiver operating characteristic curve analysis. The average prostate volume and prostate-specific antigen (PSA) were significantly increased in both groups, while prostate volume was significantly decreased in both groups. Finasteride and prostate volume correlated positively with the prostate volume in both groups. The mean prostate volume and prostate-specific antigen (PSA) were both significantly increased in both groups. Finasteride and prostate volume correlated negatively with the hair density in both groups. Finasteride was more likely to increase the prostate volume in Asian men. This study showed that the prostate volume and prostate-specific antigen were significantly increased in Filipino men with BPH and their prostate volume was significantly decreased in Asian men with BPH. Therefore, the prostate volume and prostate-specific antigen may be used to evaluate the prostate health in Filipino men with benign prostatic hyperplasia (BPH).

Finasteride was identified as the most frequent side effect of finasteride in Asian men with benign prostatic hyperplasia (BPH). The incidence of BPH was 4.1 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, 3.6 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, 1.7 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 1.9 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 2.5 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 3.6 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 1.9 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH. These data showed that the incidence of BPH was 4.1 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men with BPH, and 1.7 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 2.5 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 3.6 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 1.9 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH.

The incidence of BPH was 4.7 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, 3.6 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 1.9 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 2.5 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 3.6 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 1.9 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 2.5 cases/100,000 patient-years in Asian men with BPH compared to the incidence in Western men without BPH, and 3.

The store will not work correctly when cookies are disabled.

JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.

PROPECIA 1MG

PROPECIA 1MG is used to treat male pattern hair loss (also known as androgenetic alopecia). It also helps to prevent further hair loss caused by minoxidil (Tretinoin).

CONTRAINDICati

For men with hair loss of the scalp that is caused by exposure to androgens or alpha-blockers, the drug Propecia (finasteride) must be used under medical supervision. This drug is only used after consulting a doctor.

This drug is not recommended for use in women and children. Discuss your symptoms with your doctor before taking this medicine.

Before taking this medicine, tell your doctor if you:

• Have ever had an allergic reaction to this medicine or any other medicine
• Take any products that claim to help with hair thinning
• Experience hair loss after menopause
• Have any other medical conditions
• Take any medication regularly
• Have any allergies to medicines, chemicals, or other substances
• Are pregnant or become pregnant or are breastfeeding
• Are taking any other medication
• Are taking any other treatment for hair loss

This is not a complete list of side effects. If you notice other effects not listed above, please ask your doctor or pharmacist for more information.

latable appearance of body that changes color when exposed to itchy or painful or flaking hairline in children's book

contains the active ingredient finasteride.

Do not take this medicine if youare allergic to finasteride or any of the other ingredients listed at the end of this leaflet.

Inform your doctor if you have:

• Glaucoma
• Severe liver disease or underactive thyroid
• Kidney disease
• A blood disorder such as sickle cell anemia or multiple myeloma
• Blood cell disorder such as hemophilia
• Severe liver or kidney disease
• A tumor or family history of breast cancer
• Retinitis pigmentosa

Before taking PROPECIA, tell your doctor or pharmacist if you are taking any other medicines, including any medicines or supplements. Your doctor may need to change the doses of your medicines or monitor you carefully for side effects.

If you have not told your doctor about any of the above, tell them before you start taking this medication.

Your doctor, pharmacist, or other health care professional will determine if this medicine is right for you. Do not change the dose of your medicine.

You may needotherwise dosage changes.

Always read the label. Ask your doctor or pharmacist for the proper label.

contraindication to topical treatments or hair growth treatment

NONPREGNANCERPregnancy

This is not a complete list of possible problems with PROPECIA. If you think you may have any problems with this medicine, contact your doctor or any other health care professional.

PREGNANTLiver

This medicine may cause a decrease in liver function.

The most common side effects of Proscar include a decreased interest in sexual intercourse, inability to have or keep an erection, or a loss in sexual ability, desire, drive or performance. Talk to your doctor or a healthcare professional if symptoms persist or are severe.

You should contact your doctor immediately if you experience any of the following symptoms:

• Rash
• Changes in the breasts such as increased size, lumps, pain, or nipple discharge
• Itching
• Hives
• Swelling of the lips and face
• Difficulty breathing or swallowing

While rare, these symptoms require immediate medical attention. This is not a complete list of side effects associated with finasteride. Studies have shown that finasteride can increase your risk of developing breast cancer or high-grade prostate cancer, which spreads and grows more rapidly than other types of prostate cancer.

Studies have also shown that Proscar can affect the results of the prostate-specific antigen (PSA) test, which may be used to detect prostate cancer. Be sure to tell your healthcare provider that you are taking finasteride so that they are aware of any medication interference with PSA testing.

Proscar is only for use in men and can cause birth defects in pregnant women. If you are breastfeeding, pregnant, or plan on becoming pregnant and touch crushed or broken Proscar tablets, you should wash your hands and call your doctor right away.

Get emergency medical treatment if you have symptoms of a serious heart condition such as irregular heartbeat, chest pain, or shortness of breath; people who are pregnant or breastfeeding have significantly more risk than people who are or may become pregnant. A number of medications can affect the way Proscar works. Tell your doctor if you experience any of the following symptoms while taking Proscar:

• Feeling sick (nausea) or vomiting
• Dizziness or light-headedness
• Diarrhea
• Fatigue
• Joint pain
• Joint pain or swelling; itchy skin
• Swelling in the face, lips, or throat
• Trouble swallowing

If you experience any of the above symptoms, call your doctor.

Take a doctor’s exam if you have:

• Confusion or fatigue
• Heart rate either up or down
• New or worsening kidney disease
• Vision changes or sudden vision loss
• Have thoughts about suicide or self-harm

Take Proscar exactly as directed by your doctor. Do not take more than the prescribed dose or take it for a longer time than directed.

If you are taking alpha-blockers such as doxazosin, do not exceed the recommended dose.

Keep all doctor and pharmacist appointments and lab appointments. Your doctor may need to check your progress and side effects.

Before you start taking Proscar, tell your doctor if you:

• Have ever had low blood pressure, heart, or liver function problems
• Have as regular a kidney problem
• Have any of the following medical conditions or uncontrolled high or low blood pressure
• Have ever had a personal or family history of liver problems
• Have a history of seizures or fits
• Have ever had severe vision changes or sudden vision loss

High or low cholesterol is a risk factor for breast cancer. Ask your doctor if you have any other risk factors for breast cancer.

Finasteride can affect the way some medications work. Your doctor will do some follow-up during your treatment to check in with you to ensure that this medication is working well. If you continue to experience any changes in your vision, contact your doctor.

Tell your doctor if you are pregnant or plan to become pregnant.

Tell your doctor if you are breastfeeding or plan to breastfeed.

Finasteride side effects

Stop taking finasteride and tell your doctor if you:

High or low blood pressure, kidney problems, heart problems, or have ever had an allergic reaction to finasteride, previous side effects such as fever or rash, changes in the amount of urine, swollen legs or muscles, or trouble breathing.

Take with meals for 2 hours before you take finasteride.

Product description

Product name:FINASTERIDE

Company name:

DIN:02602906

Status:Marketed

Status date:2020-10-01

Active ingredient(s)	Strength
FINASTERIDE (FINASTERIDE)	5 MG

Resources

Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.

For consumers

Resource	Description
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections: Part I: Health Professional Information; Part II: Scientific Information; and Patient Medication Information
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are: Unexpected, regardless of their severity, i.e., not consistent with product information or labelling; or Serious, whether expected or not, i.e., that requires being admitted to the hospital, lengthened hospital stay, causes a birth defect, disability, is life-threatening or results in death; Reactions to recently marketed health products (on the market for less than five years), regardless of their nature or severity.

For health care professionals

Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals.

For researchers

After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes.

All resources